Coherus Oncology, Inc. (CHRS) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -57.89M | -19.72M | -46.34M | -46.63M | -25.83M | 28.61M | -62.02M | 59.73M | -46.77M | -12.94M | -54.3M | -38.91M |
| Operating CF Margin % | -470.24% | -154.66% | -400.48% | -454.77% | -339.86% | 52.84% | -87.63% | 91.93% | -2026.26% | -14.14% | -72.82% | -66.28% |
| Operating CF Growth % | -124.14% | -168.92% | 25.28% | -178.07% | 44.78% | 321.13% | -14.21% | 253.5% | 31.96% | 87.06% | -46.4% | 22.23% |
| Net Income | -36.94M | 241.2M | -35.53M | 297.77M | -56.57M | -50.7M | -10.75M | -54.85M | 102.88M | -79.65M | -39.64M | -42.87M |
| Depreciation & Amortization | 881K | 2.06M | 966K | 1.02M | 1.05M | 5.19M | 1.55M | 1.19M | 1.51M | 1.06M | 899K | 880K |
| Stock-Based Compensation | 0 | 10.79M | 3.39M | 5.42M | 5.37M | 6.38M | 6.44M | 0 | 7.32M | 10.8M | 9.95M | 10.08M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 874K | 0 |
| Other Non-Cash Items | 1.85M | -260.98M | -5.77M | -327.18M | 13.47M | 19.53M | -48.08M | 39.13M | -147.09M | 48.49M | 1.24M | -774K |
| Working Capital Changes | -23.68M | -12.79M | -9.39M | -23.65M | 10.86M | 48.2M | -11.17M | 74.26M | -11.38M | 6.37M | -27.62M | -6.23M |
| Change in Receivables | -4.28M | 106.16M | -4.27M | 55.27M | 50.89M | 56.33M | 7.81M | 76.64M | 8.58M | -44.06M | -75.28M | -39.88M |
| Change in Inventory | -11.31M | -18.47M | 2.48M | 3.77M | -22.24M | -6.45M | -6.94M | -7.1M | -11.46M | -11.79M | -19.23M | -13.04M |
| Change in Payables | 2.56M | 833K | -15.3M | -12.21M | 13.04M | 0 | 0 | 39.46M | 616K | -785K | 6.76M | 6.05M |
| Cash from Investing | 30.66M | -2.84M | -67.23M | 462.64M | -17.49M | -542K | 444K | 27.66M | 202.76M | 35.2M | 50.55M | 41.37M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -34K | 0 | -100K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | 0.04% | - | 0.17% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 76K | 151K | 440K |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -1.09M | -8.39M | -27K | 483.36M | -17.49M | -542K | 444K | 27.66M | 187.88M | -1.05M | 7M | 0 |
| Cash from Financing | 53.59M | 8.08M | 2K | -281.52M | -264K | 231K | -167K | -187.93M | 887K | 366K | 11.11M | 54.33M |
| Debt Issued (Net) | 0 | 0 | 0 | -233.19M | 0 | 0 | -141K | -223.27M | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 53.65M | 8.06M | 0 | 188K | -264K | -10K | -10K | 633K | 1.51M | 891K | 11.44M | 54.9M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | -264K | -10K | -10K | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -60K | 22K | 2K | -48.53M | 0 | 241K | -16K | 34.71M | -620K | -525K | -332K | -577K |
| Net Change in Cash | 26.36M | -14.47M | -113.56M | 134.48M | -43.58M | 28.3M | -61.74M | -100.53M | 156.88M | 22.18M | 7.35M | 56.77M |
| Free Cash Flow | -57.89M | -19.72M | -46.34M | -46.63M | -25.83M | 28.61M | -62.02M | 59.73M | -46.77M | -12.97M | -54.3M | -39.02M |
| FCF Margin % | -470.24% | -154.66% | -400.48% | -454.77% | -339.86% | 52.84% | -87.63% | 91.93% | -2026.26% | -14.17% | -72.82% | -66.45% |
| FCF Growth % | -124.14% | -168.92% | 25.28% | -178.07% | 44.78% | 320.55% | -14.21% | 253.11% | 32.11% | 87.03% | -44.62% | 23.38% |
| FCF per Share | -0.42 | -0.16 | -0.40 | -0.40 | -0.22 | 0.25 | -0.54 | 0.52 | -0.37 | -0.12 | -0.56 | -0.45 |
| FCF Conversion (FCF/Net Income) | 1.53x | 0.53x | 1.32x | 1.13x | 0.46x | -0.56x | 5.77x | -4.62x | -0.45x | 0.16x | 1.37x | 0.91x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 25.38M | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |